Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Promethazine misuse among methadone maintenance patients and community-based injection drug users.

Shapiro BJ, Lynch KL, Toochinda T, Lutnick A, Cheng HY, Kral AH.

J Addict Med. 2013 Mar-Apr;7(2):96-101. doi: 10.1097/ADM.0b013e31827f9b43.

2.

Promethazine use among chronic pain patients.

Lynch KL, Shapiro BJ, Coffa D, Novak SP, Kral AH.

Drug Alcohol Depend. 2015 May 1;150:92-7. doi: 10.1016/j.drugalcdep.2015.02.023. Epub 2015 Feb 26.

3.

Intravenous misuse of buprenorphine: characteristics and extent among patients undergoing drug maintenance therapy.

Moratti E, Kashanpour H, Lombardelli T, Maisto M.

Clin Drug Investig. 2010;30 Suppl 1:3-11. doi: 10.2165/11536020-000000000-00000.

PMID:
20450240
4.

Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users.

Tsui JI, Evans JL, Lum PJ, Hahn JA, Page K.

JAMA Intern Med. 2014 Dec;174(12):1974-81. doi: 10.1001/jamainternmed.2014.5416.

5.

Factors associated with depression and anxiety among patients attending community-based methadone maintenance treatment in China.

Yin W, Pang L, Cao X, McGoogan JM, Liu M, Zhang C, Li Z, Li J, Rou K.

Addiction. 2015 Jan;110 Suppl 1:51-60. doi: 10.1111/add.12780.

PMID:
25533864
6.

Use and misuse of opioid replacement therapies: a Queensland study.

Smirnov A, Kemp R.

Subst Use Misuse. 2012 Jan;47(1):78-85. doi: 10.3109/10826084.2011.629017.

PMID:
22216993
7.

Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.

Reimer J, Verthein U, Karow A, Schäfer I, Naber D, Haasen C.

Addiction. 2011 Sep;106(9):1647-55. doi: 10.1111/j.1360-0443.2011.03463.x. Epub 2011 Jul 22.

PMID:
21489005
8.

Perceived barriers to utilise methadone maintenance therapy among male injection drug users in rural areas of southern Thailand.

Khampang R, Assanangkornchai S, Teerawattananon Y.

Drug Alcohol Rev. 2015 Nov;34(6):645-53. doi: 10.1111/dar.12268. Epub 2015 Apr 13.

PMID:
25867927
9.

Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: a modeling analysis for Ukraine.

Alistar SS, Owens DK, Brandeau ML.

PLoS Med. 2011 Mar;8(3):e1000423. doi: 10.1371/journal.pmed.1000423. Epub 2011 Mar 1.

10.

Correlates of non-medical prescription drug use among a cohort of injection drug users in Baltimore City.

Khosla N, Juon HS, Kirk GD, Astemborski J, Mehta SH.

Addict Behav. 2011 Dec;36(12):1282-7. doi: 10.1016/j.addbeh.2011.07.046. Epub 2011 Aug 5.

11.

Benzodiazepine use and misuse among patients in a methadone program.

Chen KW, Berger CC, Forde DP, D'Adamo C, Weintraub E, Gandhi D.

BMC Psychiatry. 2011 May 19;11:90. doi: 10.1186/1471-244X-11-90.

12.

Detection of illicit opioid and cocaine use in methadone maintenance treatment.

Wasserman DA, Korcha R, Havassy BE, Hall SM.

Am J Drug Alcohol Abuse. 1999 Aug;25(3):561-71.

PMID:
10473015
13.

Opioid agonist treatment for pharmaceutical opioid dependent people.

Nielsen S, Larance B, Degenhardt L, Gowing L, Kehler C, Lintzeris N.

Cochrane Database Syst Rev. 2016 May 9;(5):CD011117. doi: 10.1002/14651858.CD011117.pub2. Review.

PMID:
27157143
14.

Longitudinal analysis of pain and illicit drug use behaviors in outpatients on methadone maintenance.

Dhingra L, Perlman DC, Masson C, Chen J, McKnight C, Jordan AE, Wasser T, Portenoy RK, Cheatle MD.

Drug Alcohol Depend. 2015 Apr 1;149:285-9. doi: 10.1016/j.drugalcdep.2015.02.007. Epub 2015 Feb 17.

15.

Usefulness of the Brief Pain Inventory in Patients with Opioid Addiction Receiving Methadone Maintenance Treatment.

Dennis BB, Roshanov PS, Bawor M, Paul J, Varenbut M, Daiter J, Plater C, Pare G, Marsh DC, Worster A, Desai D, Thabane L, Samaan Z.

Pain Physician. 2016 Jan;19(1):E181-95.

16.

Carriage of Staphylococcus aureus among injection drug users: lower prevalence in an injection heroin maintenance program than in an oral methadone program.

Bassetti S, Wolfisberg L, Jaussi B, Frei R, Kuntze MF, Battegay M, Widmer AF.

Infect Control Hosp Epidemiol. 2004 Feb;25(2):133-7.

PMID:
14994939
17.

Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.

Peirce JM, Petry NM, Stitzer ML, Blaine J, Kellogg S, Satterfield F, Schwartz M, Krasnansky J, Pencer E, Silva-Vazquez L, Kirby KC, Royer-Malvestuto C, Roll JM, Cohen A, Copersino ML, Kolodner K, Li R.

Arch Gen Psychiatry. 2006 Feb;63(2):201-8.

PMID:
16461864
18.

Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran.

Farnia M, Ebrahimi B, Shams A, Zamani S.

Int J Drug Policy. 2010 Sep;21(5):422-4. doi: 10.1016/j.drugpo.2010.03.008. Epub 2010 Apr 21. Review.

PMID:
20413287
19.

Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users.

Schütz CG, Rapiti E, Vlahov D, Anthony JC.

Drug Alcohol Depend. 1994 Oct;36(2):129-38.

PMID:
7851280
20.

Evaluation of an implementation of methadone maintenance treatment in China.

Marienfeld C, Liu P, Wang X, Schottenfeld R, Zhou W, Chawarski MC.

Drug Alcohol Depend. 2015 Dec 1;157:60-7. doi: 10.1016/j.drugalcdep.2015.10.001. Epub 2015 Oct 8.

Supplemental Content

Support Center